Risperdal Product Liability Trial Underway
A Philadelphia jury heard allegations this week in a lawsuit that claims Johnson & Johnson (J&J) and its Janssen Pharmaceuticals subsidiary illegally marketed the antipsychotic Risperdal to children in order to increase sales and grow the market for the drug beyond sufferers of schizophrenia. The Legal Intelligencer (subscription required) reports the allegations are from a lawsuit filed by a 17-year-old boy with Asperger’s syndrome and his